Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis

Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin

Francesca Catella-Lawson, Muredach P. Reilly, Shiv Kapoor et al. · New England Journal of Medicine · 2001 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

M.J. Peters, Deborah Symmons, David McCarey et al. · Annals of the Rheumatic Diseases · 2009 · 1.3K citations · Full text

Medicine, Cardiology, Internal Medicine +17

International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).

Nigel S. Baber · British Journal of Clinical Pharmacology · 1994 · 767 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +11

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Claudia Wahl, Susanne Liptay, G. Adler et al. · Journal of Clinical Investigation · 1998 · 740 citations · Full text

Medicine, Immunology, Pharmacology +17

Platelet Reactivity in Patients and Recurrent Events Post-Stenting

Paul A. Gurbel, Kevin P. Bliden, Kirk E. Guyer et al. · Journal of the American College of Cardiology · 2005 · 648 citations

Medicine, Cardiology, Hematology +14